Skip to main content

Diabetes, arthritis and other conditionsGuide

Raynaud's phenomenon

Raynaud's phenomenon is a temporary narrowing of small blood vessels, mostly in the fingers and toes. Cold or stress usually sets it off, and the skin turns white, then blue, then red. Keeping your whole body warm and not smoking are the first steps; sores on the fingers or toes mark a more serious form.

Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPodLast reviewed 22 November 2026 6 min read

Jump to a section
  1. 1. What is Raynaud's phenomenon?
  2. 2. What causes it, and who gets it?
  3. 3. What does Raynaud's feel like, how is it diagnosed, and can it be serious?
  4. 4. What helps first?
  5. 5. What helps if that isn't enough?
  6. 6. How long does it last, and can I stop it coming back?

At a glance

  • It's attacks of narrowed blood vessels, usually in the fingers and toes, set off by cold or emotional stress.
  • The skin often goes white, then blue, then red, though not everyone sees every colour.
  • Keeping your whole body warm comes first, along with not smoking and avoiding the triggers you notice.
  • Sores or tissue loss on a finger or toe are serious features, and can point to an underlying disease.

What is Raynaud's phenomenon?

Raynaud's phenomenon (often just called Raynaud's) is a condition where the small blood vessels in the fingers and toes briefly go into spasm and narrow, so less blood reaches the skin. An attack usually follows cold or emotional stress. The lips, nose, ears and nipples are occasionally affected too.

It is described in two forms. Primary Raynaud's has no underlying disease and usually runs a mild course. Secondary Raynaud's is linked with a connective tissue disease (an autoimmune condition such as scleroderma or lupus).

What causes it, and who gets it?

Attacks happen when the blood vessels narrow more than they normally would, most often in the cold or under emotional stress.

Primary Raynaud's usually starts in the teenage years or early adult life, and it is more common in women. It runs in families. Smoking, manual work and migraine are also linked with it, but these are associations, not proven causes.

Secondary Raynaud's comes from an underlying disease, mainly a connective tissue disease. In 10–20% of cases, Raynaud's is the first sign of one.

Some medicines can bring on attacks, including decongestants containing phenylephrine or pseudoephedrine, beta blockers, ergotamine migraine medicines and stimulants such as methylphenidate. Certain cancer medicines carry the highest risk, followed by beta blockers. It can help to keep a list of the medicines you take.

What does Raynaud's feel like, how is it diagnosed, and can it be serious?

In a typical attack the skin goes white as the blood supply drops, then blue as oxygen runs low, then red as blood flow returns. Not everyone gets every stage. Numbness, tingling or pain can come with it, and swelling, burning or throbbing can follow as circulation returns. An attack can last from a few minutes to a few hours.

There is no single test. A doctor usually diagnoses it from your description of a typical attack in the cold. Expert consensus is that white and blue colour changes, with cold as a trigger, are the minimum for a diagnosis. Nailfold capillaroscopy (a magnified look at the tiny blood vessels at the base of the nail) may be used to tell primary from secondary Raynaud's. Photographs of an attack can help you describe it. Deliberately bringing on an attack as a test was left out of the expert diagnostic approach because it could injure you.

Primary Raynaud's is entirely reversible and doesn't cause lasting tissue injury. In secondary forms, such as systemic sclerosis, severe lack of blood flow can cause ulcers, scarring and sometimes gangrene. Small, painful sores at the tips of the fingers or toes can develop in severe Raynaud's, and in rare cases an episode lasting days can lead to gangrene. In systemic sclerosis, finger ulcers are very painful, slow to heal, at high risk of infection and can be very disabling. Ulcers, open sores and tissue loss are the main serious features.

Some features point towards an underlying connective tissue disease rather than primary Raynaud's:

  • a first attack after about age 25–30
  • symptoms on one side only
  • puffy-looking hands or tightening skin
  • ulcers or pitting on the fingers or toes
  • painful joints, a rash or sensitivity to sunlight
  • dry eyes and mouth
  • weak muscles

Attacks on one side only can also point to a problem in the larger arteries instead. An attack that lasts longer than normal or doesn't ease, or attacks that carry on despite self-care, can mean circulation is worse than expected or that there is an underlying cause. Serious drug-related complications such as critical lack of blood flow to a finger are rare.

It can help to check your fingers and toes regularly for sores, cracks or skin changes, and to note whether symptoms affect one side only.

What helps first?

For most people, avoiding getting cold prevents attacks and keeps symptoms under control. The first steps are not drugs:

  • Keep your whole body warm, including your chest, abdomen and head, not just your hands and feet.
  • Dress in layers with a hat or hood, wear gloves or use heated hand warmers, and protect your hands when handling cold or frozen items.
  • Avoid nicotine. Nicotine from smoking, and from some vaping solutions, narrows blood vessels and raises the chance of an attack. Smoking may also cause permanent damage to blood vessels.
  • Cut back on caffeinated drinks and avoid triggers you have noticed.

Warming measures may reduce how often attacks happen and how long they last. How much these self-care steps help isn't clear yet.

What helps if that isn't enough?

When medicine is needed, calcium channel blockers (medicines that widen the blood vessels) are a common choice. Keeping up the self-care steps alongside any further treatment is sensible.

Severe cases with sores or gangrene can need a few days in hospital, with scans and medicines given into a vein to restore blood flow quickly and treat infection. Open sores can become infected, which may need antibiotics or even an operation.

Some medicines can worsen Raynaud's. A person with a history of it who starts one of these medicines needs careful monitoring, and alternatives that don't alter blood flow to the hands and feet should be considered where possible. It helps to include over-the-counter decongestants when you list your medicines so they can be reviewed.

How long does it last, and can I stop it coming back?

How often primary Raynaud's clears, carries on or worsens over the long term isn't clear yet. A minority of people with Raynaud's go on to develop systemic sclerosis, so new symptoms such as skin tightening, ulcers or joint problems matter even if the Raynaud's seemed mild at first.

The same steps as above, keeping warm, wearing gloves and avoiding nicotine, are the main ways to cut down attacks. Because some medicines can bring on attacks, it helps to ask about this before starting any new one.

Common questions

Is Raynaud's the same as poor circulation?

Not exactly. Raynaud's is a temporary narrowing of small blood vessels in response to cold or stress, and in the primary form it doesn't cause lasting tissue injury. Attacks that carry on despite self-care, or last longer than normal, can mean circulation is worse than expected or that there is an underlying cause.

Can stress trigger Raynaud's attacks?

Yes. Emotional stress can set off an attack, as well as cold. Because of this, reducing stress may help, although it is only one part of looking after yourself. Keeping your body warm and avoiding the other triggers you have noticed matters too.

Does Raynaud's mean I have lupus or scleroderma?

Not necessarily. Primary Raynaud's has no underlying disease and often appears on its own in teenagers and young women. Raynaud's is linked with these conditions in its secondary form, and other signs, such as skin tightening or joint pain, are what point that way.

Further reading

Want to know more? Raynaud's phenomenon on Clindice

Reviewed by Andrew Schox, BSc(Hons) PGradDipPod MPod

Podiatrist

Reviewed 22 November 2026. Next review by 22 November 2027.

How we write and review Learn

Was this page helpful?

Sources

(18)
  1. 1.Raynaud's phenomenon (secondary)Herrick A, Muir L · BMJ Clinical Evidence · 2014
  2. 2.Raynaud's PhenomenonNational Institute of Arthritis and Musculoskeletal and Skin Diseases · 2017
  3. 3.Raynaud's PhenomenonLancashire and South Cumbria NHS Foundation Trust
  4. 4.International consensus criteria for the diagnosis of Raynaud's phenomenonMaverakis E, Patel F, Kronenberg DG et al. · Journal of Autoimmunity · 2014
  5. 5.Calcium channel blockers for primary and secondary Raynaud's phenomenonRirash F, Tingey PC, Harding SE et al. · The Cochrane Database of Systematic Reviews · 2017
  6. 6.Raynaud's diseaseHealthdirect Australia
  7. 7.Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studiesGarner R, Kumari R, Lanyon P et al. · BMJ Open · 2015
  8. 8.Raynaud's Phenomenon (Guidelines)Right Decisions
  9. 9.Raynaud's PhenomenonNational Institute of Arthritis and Musculoskeletal and Skin Diseases · 2017
  10. 10.Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockersKhouri C, Blaise S, Carpentier P et al. · British Journal of Clinical Pharmacology · 2016
  11. 11.Raynaud'snidirect
  12. 12.Calcium channel blockers for primary Raynaud's phenomenonEnnis H, Hughes M, Anderson ME et al. · The Cochrane Database of Systematic Reviews · 2016
  13. 13.A PRISMA-driven systematic review for predictive risk factors of digital ulcers in systemic sclerosis patientsSilva I, Almeida J, Vasconcelos C · Autoimmunity Reviews · 2015
  14. 14.Raynaud's PhenomenonRight Decisions
  15. 15.Raynaud'sNHS
  16. 16.Systematic literature review to inform the Portuguese recommendations for the management of Raynaud's phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseasesCosta E, Cunha-Santos F, Dourado E et al. · ARP Rheumatology · 2024
  17. 17.Behaviour change interventions for the management of Raynaud's phenomenon: a systematic literature reviewDaniels J, Pauling JD, Eccleston C · BMJ Open · 2018
  18. 18.Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisKoenig M, Joyal F, Fritzler MJ et al. · Arthritis and Rheumatism · 2008

This is general information, not advice about your own situation. To discuss your issues, book with one of our podiatrists. In an emergency, call 000.

Searching…